NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


[profilepress-login id="1"]

Don't have an account? Subscribe

ADVERTISEMENT

ADVERTISEMENT

Report finds progress in lung cancer treatment but more to do

By Dermot - 16th Dec 2015

This is according to the inaugural Lung Cancer Annual Report from the Mater Misericordiae University Hospital, part of the Ireland East Hospital Group, launched today. The report contains a comprehensive review of the hospital’s key lung cancer services and provides a framework for its performance against international expert centres.

The report’s findings also include that two thirds of assessed patients receive an all-clear after initial assessment. The report also states that more young women smoke than do not and lung cancer kills more women than breast cancer.

“Significant strides have been made at the Mater recently in terms of advanced diagnostics and provision of state-of-the-art treatments for our patients with this devastating disease,” said Dr. Dermot O’Callaghan, Consultant Respiratory, General Physician and Chair of the Hospital’s Lung Cancer Working Group. “This first annual report is an important milestone in detailing the activity of our National Cancer Control Programme and highlights the high level of complex care delivered for our lung cancer patients.”

ADVERTISEMENT

Latest

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT